Meeting highlights of the 15th annual Scientific Sessions of the American Society of Echocardiography: June 26 to 30, 2004  by Gorcsan, John et al.
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Peeting Highlights of the
5th Annual Scientific Sessions of the
merican Society of Echocardiography:
une 26 to 30, 2004
ohn Gorcsan III, MD, FACC,* Roberto M. Lang, MD, FACC,† Michael H. Picard, MD, FACC,‡
illiam A. Zoghbi, MD, FACC,§ Peter C. Frommelt, MD, FACC, Linda D. Gillam, MD, FACC¶
ittsburgh, Pennsylvania; Chicago, Illinois; Boston, Massachusetts; Houston, Texas; Milwaukee, Wisconsin;
nd Hartford, Connecticut
“Echocardiography is the heart of clinical cardiology” was an appropriate theme for the 15th
Scientific Sessions of the American Society of Echocardiography. Care of the cardiovascular
patient is constantly changing, and this meeting showcased how echocardiographic and
Doppler methods continue to be critically important to detect and quantify disease, determine
response to therapy, and guide clinical decision making in contemporary medicine. This
highly successful five-day educational event attracted a record number of attendees and
focused on disease-based clinical applications of the latest technological advances in cardiac
ultrasound, including advances in diagnosis and treatment of heart failure, valvular disease,
coronary disease, and congenital disease. (J Am Coll Cardiol 2004;44:2111–6) © 2004 by
ublished by Elsevier Inc. doi:10.1016/j.jacc.2004.08.055the American College of Cardiology Foundation
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fEchocardiography is the heart of clinical cardiology” was
n appropriate theme for the 15th Scientific Sessions of
he American Society of Echocardiography (ASE) in San
iego, California. Echocardiography is truly essential to
ontemporary care of the patient with cardiovascular
isease. This highly successful five-day educational event
hat attracted a record number of attendees was chaired
y Dr. John Gorcsan III and focused on disease-based
linical applications of the latest technological advances
n cardiac ultrasound. One outstanding highlight was the
SE’s President, Dr. Randy Martin, who presented the
nge Edler lecture, named for the father of echocardiog-
aphy. Dr. Martin’s lecture, “Making a Difference in
ndividual Lives,” dramatically demonstrated how echo-
ardiography improves human health by impacting the
ndividual patient. Another highlight was Dr. Mario
arcia’s presentation of “Echocardiography Is the Key-
tone to the Evaluation of Cardiac Function” as the
arvey Feigenbaum lecture, which recognizes young
aculty who have made significant contributions to the
eld.
OUNG INVESTIGATOR COMPETITION
n important priority for the Society is to showcase the
oung Investigators who represent the future of the field of
chocardiography. Among four finalists who competed, Dr.
artho Sengupta was the winner for his work on cardiac
yofiber array (1). His group used an elegant pig model
From *University of Pittsburgh, Pittsburgh, Pennsylvania; †University of Chicago,
hicago, Illinois; ‡Massachusetts General Hospital, Boston, Massachusetts; §Baylor
ollege of Medicine, Houston, Texas; Medical College of Wisconsin, Milwaukee,
isconsin; and ¶Hartford Hospital, Hartford, Connecticut.iManuscript received August 17, 2004; revised manuscript received August 24,
004, accepted August 26, 2004.ith sonomicrometry and tissue Doppler to demonstrate
he changing transmural myocardial direction along with
on-homogenous temporal deformation within different
yocardial layers. This accounts for the changing polarity of
aveforms seen in tissue Doppler during the isovolumic
hases of the cardiac cycle. The other three investigations
ocused on newer applications of contrast echocardiography.
ohan Verjans, MS, presented a novel means of identifying
poptosis noninvasively with ultrasound in a murine model
f acute myocardial infarction (2). Contrast microspheres
ere conjugated with annexin-V, an endogenous protein
hat binds to phosphatidylserine expressed in myocytes in
arly apoptosis. Real-time contrast ultrasound showed en-
ancement in the infarct area. Peroxidase staining showed
nnexin-V within the infarct area, confirming the binding
f the microspheres. Dr. Eran Toledo presented the feasi-
ility of quantitative assessment of myocardial perfusion
sing real-time three-dimensional echocardiography in an
solated rabbit heart as well as in patients with coronary
rtery disease (3). This has the potential for more accurate
ssessment of perfusion defects compared with two-
imensional myocardial contrast echocardiography. Lastly,
r. Khim Tong presented the incremental value of regional
erfusion with contrast over regional function in patients
resenting to the emergency department with suspected
ardiac chest pain (4). Of 999 patients recruited, 16.7% had
arly cardiac events. Regional function alone increased the
rognostic information of clinical and electrocardiographic
ariables by 215%, whereas myocardial perfusion alone
ncreased it by only 157%. However, when both regional
unction and perfusion data were combined, prognostic
nformation increased by 248%. This incremental informa-
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Highlights of ASE 2004 December 7, 2004:2111–6ion of perfusion by contrast was also observed to predict
ate cardiac events.
CHOCARDIOGRAPHY IN HEART FAILURE
esynchronization therapy. Cardiac resynchronization
herapy (CRT) has been recently proposed as an alternative
reatment modality for patients with severe heart failure
HF) refractory to drug therapy. The results of clinical trials
ave shown improvements in symptoms, exercise capacity,
nd left ventricular (LV) performance with an associated
eduction in hospitalization and improved survival com-
ared with optimized medical therapy alone. An important
volving application of echocardiography is its role in CRT.
rs. Jerome Bax and John Gorcsan III were among the
aculty who gave state-of-the-art overviews on the role of
chocardiographic modalities used to predict both the re-
ponse to CRT and mechanisms of reduced mitral regurgi-
ation as well as guide optimal lead placement (5–7). They
oncluded that echocardiography, and in particular tissue
oppler methods, are promising to quantify mechanical
yssynchrony and potentially predict patient responders to
RT. Featured new data included presentations by Burgess
t al. (8) who emphasized that prolonged electrocardio-
raphic QRS duration did not accurately identify patients
ho responded to CRT, and supported the concept that
echanical echocardiographic markers of dyssynchrony play
role in identifying patient responders. They applied
olor-tissue Doppler M-mode to assess the anteroseptal to
osterior wall delay as a means to quantify LV dyssynchrony
9). Dohi et al. (10) introduced sudendocardial radial strain
s a new method to quantify mechanical dyssynchrony in an
nimal model of right ventricular (RV) pacing induced
yssynchrony. They demonstrated that radial strain dynam-
cs assessed by short-axis echocardiographic images can
uantify the degree of septal to free wall dyssynchrony
nduced by RV pacing, which mimics the native left
undle-branch block. They also showed the degree of
yssynchrony to be worsened by LV dysfunction, and
ignificantly improved with biventricular pacing. In another
ovel approach, Notomi et al. (11) used tissue Doppler to
easure myocardial torsion in degrees of apical twist before
nd after CRT, and demonstrated that patients who re-
ponded to CRT have improved myocardial torsion. Inter-
Abbreviations and Acronyms
ASE  American Society of Echocardiography
BNP  B-type natriuretic peptide
CRT  cardiac resynchronization therapy
EF  ejection fraction
HF  heart failure
LV  left ventricular
MPI  myocardial performance index
MRI  magnetic resonance imaging
RV  right ventricularstingly, Belcik et al. (12) demonstrated that myocardial tiability in ischemic HF as assessed with myocardial con-
rast echocardiography correlated linearly with the improve-
ent in symptoms and ejection fraction (EF) after CRT.
Zhang et al. (13) extended the concept of cardiac dys-
ynchrony beyond CRT and assessed 46 patients to predict
he extent of LV remodeling after acute myocardial infarc-
ion. They used magnetic resonance imaging (MRI) mea-
ures of myocardial volume and EF to show that tissue
oppler dyssynchrony was an independent predictor of
arly remodeling after infarction. Myers et al. (14) also
xtended dyssynchrony analysis to study a series of HF
atients (mean EF of 26%) and observed that mechanical
yssynchrony occurred in a significant percentage of pa-
ients with QRS duration 120 ms. These emerging data
uggest that echocardiographic markers of dyssynchrony in
atients without electrocardiographic bundle-branch block
otentially extend CRT to these patients, although this
eeds to be prospectively evaluated (14).
rognostic value in HF. B-type natriuretic peptide (BNP)
s playing a role in the diagnosis and treatment of HF
atients. Dokainish et al. (15) evaluated the prognostic value
f BNP added to echocardiography in a series of 81 patients
ith HF. Using the combined end point of cardiac death
nd hospitalization for HF, echocardiography alone pre-
icted 20 of 28 events, whereas echo-Doppler plus BNP
redicted all adverse events. The addition of BNP to
chocardiography with Doppler was cost-effective and of
owerful prognostic value (15).
ALVULAR DISEASE
itral valve disease. The Council on Intraoperative
chocardiography led by Drs. Sol Aronson and Joseph
athew presented a symposium on mitral valve disease. A
ystematic approach to evaluate each mitral component—
he annulus, leaflets, chordae, and the LV myocardium—
as emphasized. Dr. Judy Hung discussed ischemic mitral
egurgitation as an imbalance in tethering and closing forces
cting on the leaflets. Geometric remodeling of the ventricle
ith displacement of the papillary muscles and annular
ilation also increases tethering forces, and closing forces are
educed from impaired LV systolic performance. Because
schemic mitral regurgitation is a disease of the entire mitral
omplex, reducing annular size alone may be ineffective, and
ew strategies that directly address tethering by infarct
lication, papillary muscle repositioning, or basal chordal
utting to increase coaptational surface area are being
xplored. Dr. Jack Shanewise reviewed the pathophysiology
f myxomatous mitral regurgitation, discussing both seg-
ental prolapse as well as leaflet flail caused by chordal
upture. He emphasized the importance of being able to
efine the extent of myxomatous leaflet and chordal disease
s well as the location of culprit prolapsing and/or flail
egments. Dr. Joseph Sabik discussed surgical approaches to
he myxomatous valve and emphasized that successful repair
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December 7, 2004:2111–6 Highlights of ASE 2004s no longer limited to isolated flail of the middle scallop of
he posterior leaflet.
Dr. Gerald Buckberg discussed surgical approaches to LV
emodeling including revascularization of viable myocar-
ium, reduction of volume, realignment of papillary mus-
les, and reduction of annular size. Dr. Steven Bolling
dvocated mitral rings to reduce the size of dilated annuli in
atients with functional mitral valve disease. Dr. William
tewart encouraged the use of vena contracta, regurgitant
olume, and effective regurgitant orifice to quantify mitral
egurgitation, rather than color jet area alone. Percutaneous
pproaches to patients with mitral valve disease were pre-
ented where the echocardiographer plays important roles
y determining pre-procedure pathophysiology, intra-
rocedure monitoring, and assessing post-procedure out-
ome. An innovative program is planned for 2005 in Boston
hat will focus on the aortic valve and include live transmis-
ion of cases from the operating rooms of Boston area
ospitals.
hree-dimensional echocardiography. Drs. Roberto
ang and Navin Nanda reviewed current and evolving
pproaches in which three-dimensional imaging and color
ow Doppler are important for ischemic, myxomatous, and
ndocarditic valve disease where disease may be focally
ocated. Recent data included a presentation by Yosefy et al.
16) that real-time three-dimensional data can delineate the
omplexity of the isovelocity contour of valve regurgitation.
ong et al. (17) showed that three-dimensional mitral valve
eometry is a more significant factor in ischemic mitral
egurgitation than LV geometry or EF. Gill et al. (18) used
hree-dimensional echocardiography to improve the evalu-
tion of mitral stenosis before valvuloplasty and improved
he ability to predict successful outcomes in comparison to
outine echo. Daimon et al. (19) reported dynamic changes
n mitral annular geometry that occur during the cardiac
ycle, and Qin et al. (20) described the changes that occur in
he mitral valve apparatus after angioplasty repair for isch-
mic mitral regurgitation.
rosthetic valves. Dr. Linda Gillam presented a system-
tic approach for following patients with valve prosthesis,
aking the point that all prosthetic valves are intrinsically
ildly stenotic and regurgitant. She stressed the importance
f the baseline post-implantation evaluation and the role of
ntraoperative transesophageal echocardiography and the
enerally benign course of small paravalvular regurgitant jets
dentified at the time of implantation. Drs. Alfred Parisi and
ario Garcia debated the approach to patients with a
rosthetic valve thrombosis, noting that prosthetic valve
bstruction occurs as a result of thrombosis in 60% of cases,
annus in 6% of cases, and on a mixed basis in the
emainder. Although the choice of thrombolysis versus
urgery is patient dependent, the best candidates for throm-
olysis appear to be those with right-sided valve obstruction,
nd/or the thrombus is small and soft and the patient has
ot had a stroke. dORONARY ARTERY DISEASE
he most common form of cardiac disease encountered by
he practicing clinician is coronary artery disease, and this
eeting highlighted the important role that echo Doppler
ethods continue to play in its diagnosis and management.
r. Murat Tuzcu emphasized the role that intracardiac
ltrasound plays for the quantification of coronary disease
nd to determine effects of novel therapies, such as ApoA-1
ilano recently referred to as “super” high-density lipopro-
ein. Dr. Sanjiv Kaul provided an update on myocardial
ontrast perfusion imaging with a view to the myocardial
apillaries. Drs. James Thomas and Thomas Marwick
iscussed the evolving roles of tissue Doppler and strain
maging for coronary disease. Because routine visual assess-
ent of wall motion is subjective, tissue Doppler and strain
ppear to have the most promise in stress echo and viability
eterminations. Advances in signal processing and software
nalysis have made clinical applications a closer reality. Dr.
arvey Feigenbaum presented a state-of-the-art approach
ombining the aforementioned echocardiographic tech-
iques. Featured new presentations included experimental
tudies that use echo as a tool to understanding myocardial
hysiology, the introduction of new technologies and appli-
ations for the assessment of ischemic heart disease, the
volving role of contrast echo, and clinical studies with
irect patient applications.
xperimental studies. Effects of exercise on LV hypertro-
hy and remodeling as a function of age were studied in an
nimal model by Morgan et al. (21). Young and middle-
ged mice developed concentric hypertrophy during vigor-
us exercise, whereas the oldest mice developed LV dilation
nd eccentric hypertrophy. This observation may enable
urther studies into the role of arterial stiffness, resistance,
nd coupling, and this model may also be useful in studying
he effects of therapies for ventricular remodeling. Huang et
l. (22) examined the effects of mobilization of autologous
one marrow stem cells in rats after myocardial infarction.
one marrow stem cells were mobilized with injections of
ranulocyte-colony stimulating factor. Whereas ultimate
nfarct size was not different in treatment or control groups,
he degree of adverse remodeling was attenuated in the
reated group, demonstrating its potential benefit and the
aluable role of echocardiography in assessing this novel
reatment.
ew technologies and applications. Many studies utilized
issue Doppler and derived measures of strain in the setting
f ischemia and infarction. An important study by Korinek
t al. (23) found an association between alterations in
egional strain during ischemia with decreases in regional
oncentrations of high-energy nucleotides and their metab-
lites. These observations give credence to the role of strain
ate imaging as a tool to identify early aspects of the regional
schemia cascade. Another application of tissue Doppler was
o assess the “untwisting” of the ventricle that occurs during
iastole. Notomi et al. (24) demonstrated that tissue Dopp-
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Highlights of ASE 2004 December 7, 2004:2111–6er rotational velocities from short-axis views before and
fter bicycle exercise were highest during the isovolumic
hase of diastole representing enhanced rotation or LV
untwisting.” Nagashima et al. (25) studied a new biomarker
or acute myocardial infarction that has a faster release than
stablished blood markers. This biomarker, a fatty acid
inding protein, when combined with echocardiography in
he early phases of infarction had an improved accuracy for
he early (3 h) diagnosis of infarction compared with more
stablished biomarkers alone. Wall motion assessment by
cho was necessary to enhance the specificity of this biomar-
er, and echocardiography clearly plays a complementary
ole.
xercise and pharmacologic stress echo. Stress echo is
ow not only important for diagnosis but is clearly a strong
ool to assess patient prognosis and outcome. Bangalore et
l. (26) studied 1,560 patients and found that stress echo
as the most cost-effective diagnostic strategy in patients
ith intermediate to high probability of coronary artery
isease compared with a non-imaging exercise treadmill
esting followed by coronary angiography. However, a
uclear stress-testing arm was not included. Nash et al. (27)
ocused on patients older than 70 years of age who had
ormal cardiac size and function and examined clinical
arameters, exercise capacity, resting echo indices, and stress
cho indices. An impaired relaxation pattern on transmitral
alve Doppler (ratio of early transmitral flow velocity to
trial flow velocity [E/A ratio] 1) identified those with a
ubsequent lower exercise capacity and an inability to
ugment stroke volume with exercise. This impaired relax-
tion pattern may be associated with a reduced functional
apacity in the elderly (27). Alam et al. (28) demonstrated
hat viable myocardium detected by low-dose dobutamine
est was a predictor of improved EF and long-term survival
fter revascularization. Finally, a new, very small ultrasound
ransducer applied to the chest wall with full two-
imensional imaging and rotation capabilities was reported.
his has promise for continuous wall motion assessment
rom apical views during treadmill exercise (29).
ontrast echo: assessment of ventricular function. Con-
rast echocardiographic enhancement of the LV endocardial
order is routinely used clinically to assess LV function and
elineate intracardiac masses, particularly in patients with
oor acoustic windows. Hoffmann et al. (30) supported this
oncept with the results of a large multicenter European
tudy demonstrating that contrast-enhanced echocardiogra-
hy improves the interobserver agreement of biplane calcu-
ations of EF to a level that is comparable to that obtained
y MRI, believed to be the gold standard for LV volume
etermination. Caiani et al. (31) hypothesized that contrast
nhancement would improve the accuracy of LV volume
nd EF by real-time three-dimensional echocardiography as
ompared with cardiac MRI. However, contrast enhance-
ent did not improve the accuracy of three-dimensional
mages because it significantly underestimated LV volumes,
robably owing to increased bubble destruction in the lateral telds. In another study, McCulloch et al. (32) compared the
iagnostic certainty of two- and three-dimensional echocar-
iography with and without contrast in the evaluation of
uspected LV thrombus in 31 patients. The authors con-
luded that both echocardiographic modalities have similar
iagnostic capabilities in detecting LV thrombus; however,
hree-dimensional imaging improved diagnostic confidence.
ontrast echo perfusion imaging. Myocardial contrast
chocardiography is an emerging method to study myocar-
ial perfusion in patients with known or suspected coronary
rtery disease. The prognostic value of myocardial contrast
chocardiography was reported for the five-year prediction
f cardiac events in a large group of patients with confirmed
oronary artery disease (33). When all cardiac events were
nalyzed, the cumulative event for survival was 90% for
egative and 23% for positive adenosine contrast echocar-
iographic studies, respectively (log-rank  74, p 
.0001). However, a lack of current methodological unifor-
ity in the performance of myocardial perfusion stress
esting was evidenced by a myriad of abstracts proposing a
ariety of different methods. For example, McGrain et al.
34) proposed small bolus injections of Definity, instead of
he traditional continued infusions, during dipyridamole
tress. The mode of stress during perfusion imaging is also
ariable, as exemplified by Miszalski et al. (35), who
escribed the use of myocardial contrast echocardiography
uring supine bicycle stress, and by the report of Kunichika
t al. (36) on delayed imaging using high-energy ultrasound.
he majority of investigators continue to perform a subjec-
ive, experience-dependent, qualitative evaluation of con-
rast images, whereas Lodato et al. (37) proposed parametric
maging as a means of objective detection of perfusion
efects as compared with angiographic findings.
ew applications of contrast and ultrasound. This meet-
ng extended ultrasound and contrast echocardiography to
e employed for diagnostic and therapeutic purposes. Craig
t al. (38) demonstrated in an in vitro study that it is
ossible to create atrial septal perforations using high-
ensity focused ultrasound and demonstrated its potential to
alliate or treat congenital cardiac defects. Porter et al. (39)
escribed the use of contrast with real-time low mechanical
ndex pulse sequence schemes to assess endothelial dysfunc-
ion and to facilitate rapid arterial thrombolysis. Finally,
eong-Poi et al. (40) suggested that aV3-targeted
ontrast-enhanced ultrasound can be used to noninvasively
ssess angiogenic responses to chronic ischemia, even before
aximal changes in tissue perfusion.
EDIATRIC ECHOCARDIOGRAPHY
he pediatric scientific sessions program committee, led by
r. Peter Frommelt honored Dr. Stephen P. Sanders with
ts Founder’s Award for his major influence in the field of
ediatric echocardiography.
hree-dimensional echocardiography. The application of
hree-dimensional echocardiography in the assessment of
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December 7, 2004:2111–6 Highlights of ASE 2004he fetus and child with congenital heart disease was
eatured. Sklansky et al. (41) described the application of
ingle volume, real-time three-dimensional echocardiogra-
hy as a tool for prenatal screening of congenital heart
isease. Single volume data sets could be rapidly acquired to
nable visualization of all major fetal cardiac structures and
iews, improving fetal echocardiographic screening. The
edical University of South Carolina described three-
imensional echocardiographic and color Doppler recon-
truction of the aortic arch (42). They found this was
articularly useful in imaging aortic arch abnormalities and
ortopulmonary shunts.
he right ventricle. Echocardiographic assessment of the
ight ventricle remains a challenging aspect of congenital
ardiac imaging, and innovative approaches to evaluation of
V performance were presented. The application of color
oppler tissue imaging for the evaluation of RV systolic
unction in patients with congenital heart disease was
escribed in a heterogeneous group of children and adults
ith congenital heart disease that resulted in either RV
ressure overload or RV dilation (43). Peak systolic velocity
nd isovolumic acceleration at the lateral tricuspid annulus
ere found to be significant predictors of RVEF obtained
rom cine-MRI imaging when adjusted for age, RV dila-
ion, and pressure overload. Dr. Judith Therrien et al. used
he myocardial performance index (MPI) to assess systemic
V function in patients with transposition of the great
rteries after atrial switch palliation (44). They found that
PI correlated well with MRI-derived RVEF. An MPI
alue of 0.7 accurately predicted an EF 30%, and an
PI 0.4 accurately predicted an EF of 50%. It appears
hat both of these techniques hold real promise in the
ssessment of RV function in congenital heart disease.
mall animal models. Yu et al. (45) described the appli-
ation of the myocardial performance index in hamsters
enetically altered for early cardiac dysfunction. The MPI
as useful in predicting survival in this animal model of HF
nd was better at assessing prognosis than percent fractional
hortening of the left ventricle. In a separate study, a
ollaborative team led by Dr. Colin Phoon used a 40-MHz
iomicroscopy Doppler probe to study embryonic mice with
known fatal genetic mutation that results in lack of
evelopment of the aortic and pulmonary valves (46). They
ound reduced cardiac output, altered placental flow, and
iastolic dysfunction to contribute to HF and death in mice
ith the mutation. This probe elegantly described the
omplex physiology that can result in embryonic HF and
rovides an additional tool in the assessment of small animal
enetic modeling of heart disease.
ONCLUSIONS
are of the cardiovascular patient is ever changing at a fast
ace. This meeting showcased how echocardiographic and
oppler methods continue to be critically important to
etect and quantify disease, determine response to therapy,nd guide clinical decision making in contemporary medi-
ine. Dr. Sanjiv Kaul as next year’s program chair and
urrent ASE President Dr. Linda Gillam are organizing an
nnovative and exciting educational program for June 15 to
8, 2005 in Boston, Massachusetts, as the 16th Annual
cientific Sessions, which should not be missed.
eprint requests and correspondence: Dr. John Gorcsan III, Uni-
ersity of Pittsburgh, Scaife 564, 200 Lothrop Street, Pittsburgh,
ennsylvania 15213-2582. E-mail: gorcsanj@msx.upmc.edu.
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